Boothbay Fund Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.6M | Hold |
529,503
| – | – | 0.11% | 181 |
|
|
2025
Q1 | $7.96M | Hold |
529,503
| – | – | 0.21% | 93 |
|
|
2024
Q4 | $8.72M | Buy |
529,503
+25,665
| +5% | +$422K | 0.21% | 104 |
|
|
2024
Q3 | $12.4M | Buy |
503,838
+1,888
| +0.4% | +$46.6K | 0.28% | 39 |
|
|
2024
Q2 | $12.7M | Sell |
501,950
-224
| -0% | -$5.67K | 0.3% | 38 |
|
|
2024
Q1 | $12.8M | Sell |
502,174
-7,348
| -1% | -$187K | 0.25% | 40 |
|
|
2023
Q4 | $11.5M | Sell |
509,522
-108,080
| -17% | -$2.45M | 0.29% | 37 |
|
|
2023
Q3 | $11.5M | Buy |
617,602
+128,975
| +26% | +$2.4M | 0.27% | 43 |
|
|
2023
Q2 | $12.7M | Buy |
488,627
+1,630
| +0.3% | +$42.3K | 0.28% | 29 |
|
|
2023
Q1 | $14M | Buy |
486,997
+119,487
| +33% | +$3.43M | 0.29% | 30 |
|
|
2022
Q4 | $10.9M | Buy |
367,510
+197,510
| +116% | +$5.85M | 0.25% | 34 |
|
|
2022
Q3 | $4.05M | Buy |
+170,000
| New | +$4.05M | 0.1% | 215 |
|
|
2016
Q4 | – | Sell |
-4,298
| Closed | -$206K | – | 677 |
|
|
2016
Q3 | $206K | Buy |
+4,298
| New | +$206K | 0.04% | 464 |
|